🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label expanded access protocol for the treatment of up to a...
Status
No Longer Available
Location
Children's Hospital Colorado
Start Date
TBD
Trial ID
NCT02473497
Treatments Being Tested
To observe the safety, tolerability and clinical effects of crizotinib comb...
Status
Unknown
Location
Oncology Department of The First Affiliated Hospital of Zhengzhou University
Start Date
2018-10-01
Trial ID
NCT03707847
Treatments Being Tested
A phase 3 study to evaluate the efficacy and safety of SY-3505 vs. crizotin...
Status
Not Yet Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2024-05-01
Trial ID
NCT06254599
Treatments Being Tested
This non-randomized, open-label, multicenter study will evaluate the safety...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2013-09-30
Trial ID
NCT01871805
Treatments Being Tested
Brigatinib is a medicine that binds to the surface of tumor cells in some c...
Status
Completed
Location
The Oncology Institute of Hope and Innovation
Start Date
2019-04-19
Trial ID
NCT03596866
Treatments Being Tested
This randomized, multicenter, Phase III, open-label study will evaluate the...
Status
Active Not Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2021-12-31
Trial ID
NCT06569420
Treatments Being Tested
This open-label, non-randomized, multicenter, Phase 1/2 study will evaluate...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2013-06-20
Trial ID
NCT01801111
This randomized, active controlled, multicenter phase III open-label study ...
Status
Completed
Location
North Valley Hem Onc Med Grp
Start Date
2014-08-19
Trial ID
NCT02075840
Treatments Being Tested
A single-arm, open-label, multicenter, phase II study. Treatment with LDK37...
Status
Completed
Location
Highlands Oncology Group Dept of Highlands Oncology Grp
Start Date
2012-11-26
Trial ID
NCT01685060
Treatments Being Tested
The trial consists of a series of parallel multi-centre single arm phase II...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2015-05-13
Trial ID
NCT02664935